Skip to content

Effects of ultrasound-guided posterior quadratus lumborum block combined with patient-controlled intravenous analgesia on postoperative pain and early recovery quality in patients undergoing laparoscopic partial nephrectomy

Effects of ultrasound-guided posterior quadratus lumborum block combined with patient-controlled intravenous analgesia on postoperative pain and early recovery quality in patients undergoing laparoscopic partial nephrectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053439
Enrollment
Unknown
Registered
2021-11-21
Start date
2021-11-22
Completion date
Unknown
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney cancer patients

Interventions

Quadratus lumbosum block combined with patient-controlled analgesia group:quadratus lumbosum block
patient controlled analgesia group:blank control

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with elective laparoscopic partial nephrectomy 2. ASA classification I to II, no gender restriction, age 18 to 65 years; 3. Body mass index (BMI) < 28kg/m2;

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular and cerebrovascular diseases, such as grade 3 hypertension, angina pectoris, severe arrhythmia, severe heart valve disease, cerebral infarction, etc.; 2. Neurological diseases or somatosensory abnormalities; 3. History of chronic pain and long-term use of analgesics; 4. Mental illness, patients who cannot understand and cooperate; 5. Skin infection near the puncture point; 6. History of local anesthetic allergy. 7. Abnormal renal function; 8. Intraoperative blood transfusion, intraoperative use of exogenous hormone drugs such as dexamethasone and methylprednisolone; 9. Impaired glucose tolerance or diabetes; 10. Hyperfunction or hypofunction of adrenal cortex; 11. Operation time > 3h.

Design outcomes

Primary

MeasureTime frame
Dosage of sufentanil;15-item postoperative recovery quality scale score;

Countries

China

Contacts

Public ContactChai Jun

Shengjing Hospital of China Medical University

chaij@sj-hospital.org+86 18940259928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026